The Performance Measures Project: Improving Performance Measurement and Monitoring by CDC Programs
Part B: Statistical Methods
October 21, 2022
Contact: J. Stan Lehman
Telephone: (404) 639-2041
E-mail: [email protected]
Program Performance and Evaluation Office
Office of the Associate Director for Policy and Strategy
Office of the Director
Centers for Disease Prevention and Control
Atlanta, Georgia
TABLE OF CONTENTS
1. Respondent Universe and Sampling Methods
2. Procedures for the Collection of Information
3. Methods to Maximize Response Rates and Deal with No Response
4. Test of Procedures or Methods to be Undertaken
5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data
List of Attachments
Authorizing Legislation
Sample Performance Measure Technical Specification Instrument
Sample Performance Measure Reporting Instrument
GenIC Request Template for CDC Programs
60 Day Federal Register Notice
Federal Register Notice Comments
Research Determination (1 of 2)
Research Determination (2 of 2)
GENIC Completion and Carryover Report (includes a list of previously approved GENICs submitted for continuation as part of the Revision ICR)
B. Collections of Information Employing Statistical Methods
Respondent Universe and Sampling Methods
CDC/ATSDR programs are eligible to request OMB approval through the Performance Measures Project (“PMP”) generic if they have collaborated with CDC’s Program Performance and Evaluation Office (PPEO) to develop their Notice of Funding Opportunity (NOFO) or other funding announcement and have developed a core set of priority performance measures and data reporting plans for recipients. Collaboration with PPEO ensures that appropriate performance and evaluation principles are incorporated into the activities and reporting plans for these awards. PPEO anticipates that the majority of programmatic activities will be funded through the cooperative agreement mechanism but is expanding eligibility to include activities funded through grants or contracts. Eligibility is limited to non-research activities but includes qualifying activities conducted in domestic or international settings.
Information will be collected from the recipients of qualifying awards. Recipients (“respondents”) will typically be units of state or local government (e.g., state or local health departments) but may include other public health partners (e.g., private sector organizations or ministries of health).
Performance monitoring is required. No statistical sampling method will be used.
Five GENICs were approved in the previous approval period (January 2020 – January 2023) and CDC/ATSDR requests OMB approval to continue these information collections. In addition, CDC/ATSDR anticipates that up to 40 new programs will be phased in to the PMP over the next 3 years.
Procedures for the Collection of Information
The CDC/ATSDR program funding a particular public health initiative will collect information from each recipient on the schedule required by the funding mechanism and documented in the Program’s Data Management Plan. Recipients will report progress on their performance measures using a cooperative agreement-specific information collection adapted from a Sample Performance Measure Technical Specification Instrument (Attachment 4) and a Sample Performance Measure Reporting Instrument (Attachment 5). Instructions will be provided to recipients for completing the templates.
Methods to Maximize Response Rates and Deal with Nonresponse
Periodic reporting based on requirements stated in the funding mechanism is required of all recipients. Response rates are expected to be 100%.
Test of Procedures or Methods to be Undertaken
No testing of procedures or methods will be undertaken. The request is based on the recent approval of a similar generic clearance (OMB approval number: 0970-0490, expiration date 1/31/2020) for the Administration for Children and Families (ACF) and CDC’s experience with the PMP generic. All recipients receiving funding from a specific NOFO will use the NOFO-specific tool.
Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data
The individuals responsible for design and management of the information collection include:
J. Stan Lehman, epidemiologist, CDC/OD/OADPS/PPEO, [email protected]
-
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| File Title | OFFICE OF MANAGEMENT AND BUDGET |
| Author | rst8 |
| File Modified | 0000-00-00 |
| File Created | 2024-11-14 |